Michael A Via

Summary

Affiliation: Beth Israel Medical Center
Country: USA

Publications

  1. pmc Bromocriptine approved as the first medication to target dopamine activity to improve glycemic control in patients with type 2 diabetes
    Michael A Via
    Division of Endocrinology and Metabolism, Albert Einstein College of Medicine, Beth Israel Medical Center, New York, NY, USA
    Diabetes Metab Syndr Obes 3:43-8. 2010
  2. pmc The malnutrition of obesity: micronutrient deficiencies that promote diabetes
    Michael Via
    Division of Endocrinology and Metabolism, Beth Israel Medical Center, Albert Einstein College of Medicine, 55 East 34th St, USA
    ISRN Endocrinol 2012:103472. 2012
  3. doi request reprint The role of bariatric surgery in the treatment of type 2 diabetes: current evidence and clinical guidelines
    Michael A Via
    Division of Endocrinology and Metabolism, Beth Israel Medical Center, Albert Einstein College of Medicine, 55 East 34th St, New York, NY, 10016, USA
    Curr Atheroscler Rep 15:366. 2013
  4. ncbi request reprint Malnutrition, dehydration, and ancillary feeding options in dysphagia patients
    Michael A Via
    Division of Endocrinology and Metabolism, Albert Einstein College of Medicine, Beth Israel Medical Center, 55 East 34th Street, New York, NY 10016, USA Electronic address
    Otolaryngol Clin North Am 46:1059-71. 2013
  5. ncbi request reprint Intravenous ibandronate acutely reduces bone hyperresorption in chronic critical illness
    Michael A Via
    Division of Endocrinology and Metabolism, Albert Einstein College of Medicine, Beth Israel Medical Center, New York, NY 10016, USA
    J Intensive Care Med 27:312-8. 2012
  6. doi request reprint Impaired postoperative hyperglycemic stress response associated with increased mortality in patients in the cardiothoracic surgery intensive care unit
    Michael A Via
    Division of Endocrinology and Metabolism, Albert Einstein College of Medicine, Beth Israel Medical Center, New York, New York, USA
    Endocr Pract 16:798-804. 2010
  7. doi request reprint Inpatient enteral and parenteral [corrected] nutrition for patients with diabetes
    Michael A Via
    Division of Endocrinology and Metabolism, Beth Israel Medical Center, Albert Einstein College of Medicine, 55 East 34th Street, New York, NY 10016, USA
    Curr Diab Rep 11:99-105. 2011
  8. doi request reprint Metabolic management following bariatric surgery
    Erika Strohmayer
    Mount Sinai School of Medicine, New York, NY, USA
    Mt Sinai J Med 77:431-45. 2010
  9. ncbi request reprint Bone physiology and therapeutics in chronic critical illness
    Michael A Via
    Division of Endocrinology and Metabolism, Beth Israel Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA
    Ann N Y Acad Sci 1211:85-94. 2010

Detail Information

Publications9

  1. pmc Bromocriptine approved as the first medication to target dopamine activity to improve glycemic control in patients with type 2 diabetes
    Michael A Via
    Division of Endocrinology and Metabolism, Albert Einstein College of Medicine, Beth Israel Medical Center, New York, NY, USA
    Diabetes Metab Syndr Obes 3:43-8. 2010
    ..We review the available data from these four trials and other published studies. Bromocriptine is a promising therapy for diabetes patients and demonstrates modest improvements in glycemic control...
  2. pmc The malnutrition of obesity: micronutrient deficiencies that promote diabetes
    Michael Via
    Division of Endocrinology and Metabolism, Beth Israel Medical Center, Albert Einstein College of Medicine, 55 East 34th St, USA
    ISRN Endocrinol 2012:103472. 2012
    ..This paper reviews the current evidence supporting this hypothesis...
  3. doi request reprint The role of bariatric surgery in the treatment of type 2 diabetes: current evidence and clinical guidelines
    Michael A Via
    Division of Endocrinology and Metabolism, Beth Israel Medical Center, Albert Einstein College of Medicine, 55 East 34th St, New York, NY, 10016, USA
    Curr Atheroscler Rep 15:366. 2013
    ..Clinicians may consider the use of bariatric surgery as a treatment option for certain obese patients with T2D who have failed intensive lifestyle intervention and conventional pharmacotherapy. ..
  4. ncbi request reprint Malnutrition, dehydration, and ancillary feeding options in dysphagia patients
    Michael A Via
    Division of Endocrinology and Metabolism, Albert Einstein College of Medicine, Beth Israel Medical Center, 55 East 34th Street, New York, NY 10016, USA Electronic address
    Otolaryngol Clin North Am 46:1059-71. 2013
    ..Dietary modification, the addition of oral supplements, or the use of nutritional support in the form of enteral tube feeds or parenteral nutrition infusions can greatly impact the overall health of the patient. ..
  5. ncbi request reprint Intravenous ibandronate acutely reduces bone hyperresorption in chronic critical illness
    Michael A Via
    Division of Endocrinology and Metabolism, Albert Einstein College of Medicine, Beth Israel Medical Center, New York, NY 10016, USA
    J Intensive Care Med 27:312-8. 2012
    ..The measurement of bone turnover markers reveals that osteoclastic bone resorption is not only enhanced but also uncoupled from osteoblastic bone formation. We examine the effect of ibandronate on bone turnover in patients with CCI...
  6. doi request reprint Impaired postoperative hyperglycemic stress response associated with increased mortality in patients in the cardiothoracic surgery intensive care unit
    Michael A Via
    Division of Endocrinology and Metabolism, Albert Einstein College of Medicine, Beth Israel Medical Center, New York, New York, USA
    Endocr Pract 16:798-804. 2010
    ..To describe the association of tight glycemic control with intensive insulin therapy and clinical outcome among patients in the cardiothoracic surgery intensive care unit...
  7. doi request reprint Inpatient enteral and parenteral [corrected] nutrition for patients with diabetes
    Michael A Via
    Division of Endocrinology and Metabolism, Beth Israel Medical Center, Albert Einstein College of Medicine, 55 East 34th Street, New York, NY 10016, USA
    Curr Diab Rep 11:99-105. 2011
    ..Judicious use of insulin or other glucose-lowering medications synchronized with appropriate nutrition support allows for optimal inpatient glycemic control...
  8. doi request reprint Metabolic management following bariatric surgery
    Erika Strohmayer
    Mount Sinai School of Medicine, New York, NY, USA
    Mt Sinai J Med 77:431-45. 2010
    ..Testosterone levels in men also improve after surgery. Consideration of these nutritional, metabolic, and hormonal changes allows for optimal medical management following bariatric surgery...
  9. ncbi request reprint Bone physiology and therapeutics in chronic critical illness
    Michael A Via
    Division of Endocrinology and Metabolism, Beth Israel Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA
    Ann N Y Acad Sci 1211:85-94. 2010
    ..We review the mechanisms by which these factors contribute to the metabolic bone disease of chronic critical illness and suggest potential therapeutics...